X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13669) 13669
Book Review (1296) 1296
Publication (714) 714
Conference Proceeding (63) 63
Magazine Article (40) 40
Dissertation (37) 37
Book Chapter (24) 24
Paper (12) 12
Reference (4) 4
Data Set (3) 3
Web Resource (3) 3
Newspaper Article (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9817) 9817
atorvastatin (8901) 8901
humans (8147) 8147
male (5926) 5926
atorvastatin calcium (5045) 5045
female (4849) 4849
statins (4575) 4575
middle aged (4101) 4101
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3328) 3328
aged (3126) 3126
cholesterol (2743) 2743
pyrroles - therapeutic use (2632) 2632
heptanoic acids - therapeutic use (2629) 2629
cardiac & cardiovascular systems (2622) 2622
simvastatin (2597) 2597
pharmacology & pharmacy (2405) 2405
animals (2222) 2222
treatment outcome (2073) 2073
adult (2062) 2062
pyrroles - pharmacology (1687) 1687
heptanoic acids - pharmacology (1682) 1682
atherosclerosis (1634) 1634
risk factors (1610) 1610
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (1600) 1600
pravastatin (1555) 1555
abridged index medicus (1538) 1538
cholesterol, ldl - blood (1514) 1514
anticholesteremic agents - therapeutic use (1448) 1448
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (1370) 1370
pyrroles - administration & dosage (1333) 1333
heptanoic acids - administration & dosage (1331) 1331
peripheral vascular disease (1328) 1328
risk (1306) 1306
prevention (1299) 1299
lipids (1272) 1272
therapy (1236) 1236
hypercholesterolemia (1213) 1213
medicine, general & internal (1131) 1131
coronary-heart-disease (1130) 1130
rats (1118) 1118
hypercholesterolemia - drug therapy (1114) 1114
inflammation (1107) 1107
rosuvastatin (1082) 1082
statin (1077) 1077
cardiovascular disease (1042) 1042
disease (1035) 1035
dose-response relationship, drug (1021) 1021
analysis (1020) 1020
drug therapy (1019) 1019
antilipemic agents (1012) 1012
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (973) 973
cardiovascular-disease (880) 880
care and treatment (880) 880
c-reactive protein (876) 876
time factors (868) 868
cardiovascular (858) 858
drug therapy, combination (843) 843
mortality (835) 835
myocardial-infarction (833) 833
research (822) 822
cardiovascular diseases (805) 805
double-blind method (799) 799
prospective studies (794) 794
efficacy (784) 784
cholesterol - blood (777) 777
statin therapy (763) 763
mice (752) 752
simvastatin - therapeutic use (736) 736
safety (719) 719
expression (689) 689
coronary heart disease (675) 675
events (669) 669
lipids - blood (664) 664
oxidative stress (660) 660
anticholesteremic agents - administration & dosage (655) 655
diabetes (653) 653
aged, 80 and over (642) 642
follow-up studies (642) 642
metaanalysis (642) 642
pyrroles - adverse effects (641) 641
cardiology (640) 640
heptanoic acids - adverse effects (639) 639
triglycerides - blood (633) 633
low density lipoproteins (630) 630
cardiovascular agents (629) 629
cardiovascular diseases - prevention & control (620) 620
ezetimibe (608) 608
medicine, research & experimental (606) 606
rosuvastatin calcium (606) 606
anticholesteremic agents - pharmacology (587) 587
acute coronary syndromes (586) 586
coa reductase inhibitors (583) 583
cholesterol, hdl - blood (579) 579
hyperlipidemias - drug therapy (564) 564
biochemistry & molecular biology (554) 554
biomarkers - blood (547) 547
hypertension (546) 546
health aspects (544) 544
retrospective studies (543) 543
clinical trials (542) 542
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12885) 12885
Spanish (169) 169
Russian (166) 166
German (137) 137
Chinese (132) 132
French (87) 87
Japanese (37) 37
Polish (28) 28
Korean (27) 27
Portuguese (24) 24
Persian (23) 23
Hungarian (20) 20
Turkish (20) 20
Italian (14) 14
Croatian (8) 8
Ukrainian (7) 7
Czech (6) 6
Swedish (5) 5
Dutch (4) 4
Norwegian (4) 4
Danish (3) 3
Lithuanian (2) 2
Slovenian (2) 2
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Heart Journal, ISSN 1349-2365, 2019
The initiation and progression of atherosclerotic cardiovascular disease (ASCVD) has always been associated with a series of risk factors. Evidences of statin... 
Atorvastatin
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, pp. C174 - C175
Journal Article
by Cao, Z and Wang, Y and Xiao, L and Liu, Z and Zheng, Y
Chinese Journal of Bioprocess Engineering, ISSN 1672-3678, 01/2013, Volume 11, Issue 1, pp. 17 - 22
t-butyl 6-cyano-(3/R,5R)-dihydroxyhexanoate, a key chiral building block for atorvastatin, was synthesized through asymmetric reduction of... 
Atorvastatin
Journal Article
International Journal of Chemical Sciences, ISSN 0972-768X, 01/2010, Volume 8, Issue 4, pp. 2173 - 2179
Three new simple, accurate and precise spectrophotometric methods have been developed for simultaneous determination of telmisartan and atorvastatin calcium in... 
Atorvastatin
Journal Article
International Journal of Chemical Sciences, ISSN 0972-768X, 01/2010, Volume 8, Issue 4, pp. 2173 - 2179
Three new simple, accurate and precise spectrophotometric methods have been developed for simultaneous determination of telmisartan and atorvastatin calcium in... 
Atorvastatin
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 08/2019, Volume 101, pp. 707 - 708
Journal Article
Drug Development and Industrial Pharmacy, ISSN 0363-9045, 4/2015, Volume 41, Issue 4, pp. 594 - 604
Journal Article
10/2011
Drugs account for 1-2% of all cases of pancreatitis. A 58-year-old man was prescribed atorvastatin 10 mg for 6 months for hyperlipidemia. He developed acute... 
pancreatitis | Adverse drug reaction | atorvastatin
Web Resource
Journal Article
NEUROLOGY, ISSN 0028-3878, 08/2016, Volume 87, Issue 7, pp. 746 - 746
Journal Article
Journal Article
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 05/2016, Volume 504, Issue 1-2, pp. 70 - 79
Journal Article
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 11/2017, Volume 143, Issue 3, pp. 359 - 374
We report that ortho‐hydroxy atorvastatin (o‐ ATV ), which increased glutamate uptake, increased pCREB and provided neuroprotection post‐oxygen/glucose... 
ortho‐hydroxy atorvastatin | receptors | ) | cAMP | OGD | ergic neurons | synaptic | CREB | neuroprotection | GABA | NMDA | response element‐binding protein | oxygen and glucose deprivation | GABAergic neurons | oxygen and glucose deprivation (OGD) | cAMP response element-binding protein (CREB) | synaptic NMDA receptors | ortho-hydroxy atorvastatin | CREB PHOSPHORYLATION | NMDA RECEPTORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOCAL CEREBRAL-ISCHEMIA | DOPAMINERGIC-NEURONS | NEUROSCIENCES | RAT MODEL | IN-VITRO | ACUTE-PHASE | LIPID RAFTS | METHYL-D-ASPARTATE | Cell Hypoxia - drug effects | Embryo, Mammalian | Cells, Cultured | Receptors, N-Methyl-D-Aspartate - metabolism | GABAergic Neurons - drug effects | Rats | Male | Atorvastatin - pharmacology | Cerebral Cortex - cytology | Rats, Sprague-Dawley | Nerve Tissue Proteins - metabolism | CREB-Binding Protein - metabolism | Glucose - deficiency | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Female | Glutamic Acid - pharmacokinetics | Atorvastatin - analogs & derivatives | Cell Death - drug effects | Tritium - pharmacokinetics | Methyl aspartate | Metabolites | Neurons | Glucose | Glutamate | Statins | Dextrose | Protein binding | Glutamic acid | Neuroprotection | Deprivation | Oxygen | Cell survival | Glutamic acid receptors (ionotropic) | Cortex | N-Methyl-D-aspartic acid receptors | Cultures | Pharmacology | Glutamic acid receptors | Glutamate decarboxylase | Cyclic AMP response element-binding protein | Survival | Receptors | γ-Aminobutyric acid | Rodents | Atorvastatin | Survival factor | All terrain vehicles | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10088, pp. 2473 - 2481
Summary Background In blinded randomised controlled trials, statin therapy has been associated with few adverse events (AEs). By contrast, in observational... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | CLINICAL-TRIALS | CARDIOVASCULAR-DISEASE | PREVENTION | RISK | INTOLERANCE | PARTICIPANTS | Hematologic Diseases - chemically induced | Hypolipidemic Agents - adverse effects | Atorvastatin - adverse effects | Double-Blind Method | Nocebo Effect | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Atorvastatin - administration & dosage | Sleep Wake Disorders | Early Termination of Clinical Trials | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Lymphatic Diseases - chemically induced | Hypolipidemic Agents - administration & dosage | Hypertension - complications | Adult | Female | Hypercholesterolemia - prevention & control | Aged | Muscular Diseases - chemically induced | Clinical trials | Medicine, Experimental | Complications and side effects | Medical research | Epidemiology | Statins | Analysis | Cardiac patients | Sexual disorders | Risk factors | Myocardial infarction | Heart | Therapy | Laboratories | Funding | Physicians | Disorders | Impairment | Cognitive ability | Lipids | Cardiovascular disease | Angina | Matching | Connective tissues | Disturbance | Heart diseases | Public health | Hypertension | Medical personnel | Lymphatic system | Fasting | Effectiveness | Kidneys | Health risks | Erectile dysfunction | Risk analysis | Patients | Low density lipoprotein | Cholesterol | Doctors | Side effects | Sleep | Atorvastatin | Infarction | Health risk assessment | Cardiovascular diseases | Kidney transplantation | Index Medicus | Abridged Index Medicus | Clinical Medicine | management | clinical-trials | intolerance | risk | cardiovascular-disease | Klinisk medicin | General & Internal Medicine | prevention | participants
Journal Article